Compare Cytokinetics Inc (CYTK) vs Phillips 66 (PSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Phillips 66 — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Phillips 66 trades at $223.5 (market cap $89.52B). The key difference: Phillips 66 is far larger — about 8.4× Cytokinetics Inc's market cap, and Phillips 66 pays a 2.26% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | PSX | |
|---|---|---|
Market Cap | $10.63B | $89.52B |
Sector | Technology | Energy |
52-Week High | $87.26 | $224.36 |
52-Week Low | $34.31 | $120.04 |
Enterprise Value | $10.74B | $105.99B |
Dividend Yield | — | 2.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Phillips 66
Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Read more on PSX →
